Demis Hassabis, co-founder and CEO of Google DeepMind, envisions a future where artificial intelligence could revolutionize human health, potentially eliminating all diseases within the next decade.

In a recent interview with CBS News, Hassabis emphasized the rapid advancements in AI technology, describing its progress as being on an 'exponential curve of improvement.'

Despite his optimism, Hassabis cautioned about the potential misuse of AI, emphasizing the importance of aligning AI systems with human values and establishing ethical standards.

Looking ahead, Hassabis predicts that artificial general intelligence (AGI) could be realized within the next five to ten years, fundamentally transforming human interaction with technology.

He predicts that the integration of AI in drug development may lead to a state of 'radical abundance,' where scarcity of treatments could be a thing of the past.

DeepMind's AI model, AlphaFold, has made significant strides by mapping over 200 million protein structures in under a year, a task that previously took years, showcasing AI's potential in biological research.

Hassabis highlighted that traditional drug development processes can take up to ten years and cost billions, but AI has the potential to shorten this timeline to mere months or weeks.

AI is already making notable impacts in healthcare, including advancements in drug discovery and personalized treatments, such as successful automated IVF procedures.

AI's capabilities now include simulating drug behavior and predicting toxicity, which could significantly reduce the long-standing 90% failure rate in drug development.

He acknowledged the ongoing race for AI dominance among various companies and stressed the need for international cooperation to address safety and ethical considerations.

Understanding protein structures is crucial for identifying disease mechanisms and developing targeted treatments, reinforcing the importance of AI in advancing medical science.

His vision has garnered support from industry peers, including Aravind Srinivas, CEO of Perplexity, who praised Hassabis as a genius and urged for resources to help realize this ambitious vision.